NYMC Faculty Publications

Practice Variation Among Pediatric Endocrinologists in the Dosing of Glucocorticoids in Young Children With Congenital Adrenal Hyperplasia

Heba Al-Rayess, Department of Pediatrics, Division of Endocrinology, University of Minnesota Medical School, Minneapolis, MN 55454, USA.Follow
Amit Lahoti, Department of Pediatrics, Division of Endocrinology, Nationwide Children's Hospital at The Ohio State University, Columbus, OH 43205, USA.
Leslie Long Simpson, Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, MN 55455, USA.
Elise Palzer, Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, MN 55455, USA.
Paul Thornton, Division of Endocrinology and Diabetes, Cook Children's Medical Center, Fort Worth, TX 76104, USA.
Ryan Heksch, Center for Diabetes and Endocrinology, Department of Pediatrics, Akron Children's Hospital, Akron, OH 44308, USA.
Manmohan Kamboj, Department of Pediatrics, Division of Endocrinology, Nationwide Children's Hospital at The Ohio State University, Columbus, OH 43205, USA.
Takara Stanley, Pediatric Endocrine Unit and Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Molly O. Regelmann, Division of Pediatric Endocrinology and Diabetes, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY 10467, USA.
Anshu Gupta, Division of Pediatric Endocrinology, Children's Hospital of Richmond, Virginia Commonwealth University, Richmond, VA 23298, USA.
Vandana Raman, Department of Pediatrics, Division of Pediatric Endocrinology, University of Utah, Salt Lake City, UT 84112, USA.
Shilpa Mehta, Department of Pediatrics, Division of Pediatric Endocrinology and Diabetes, New York Medical College, Valhalla, NY 10595, USA.
Mitchell E. Geffner, The Saban Research Institute, Children's Hospital Los Angeles, The Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.
Kyriakie Sarafoglou, Department of Pediatrics, Division of Endocrinology, University of Minnesota Medical School, Minneapolis, MN 55454, USA.

Author Type(s)

Faculty

DOI

10.3390/children10121871

Journal Title

Children

Document Type

Article

Publication Date

11-29-2023

Department

Pediatrics

Abstract

A Pediatric Endocrine Society (PES) Drugs and Therapeutics Committee workgroup sought to determine the prescribing practices of pediatric endocrinologists when treating children <10 years of age with congenital adrenal hyperplasia (CAH). Our workgroup administered a 32-question online survey to PES members. There were 187 respondents (88.9% attending physicians), mostly from university-affiliated clinics (~80%). Ninety-eight percent of respondents prescribed the short-acting glucocorticoid hydrocortisone to treat young children, as per the Endocrine Society CAH Guidelines, although respondents also prescribed long-acting glucocorticoids such as prednisolone suspension (12%), prednisone tablets (9%), and prednisone suspension (6%). Ninety-seven percent of respondents indicated that they were likely/very likely to prescribe hydrocortisone in a thrice-daily regimen, as per CAH Guidelines, although 19% were also likely to follow a twice-daily regimen. To achieve smaller doses, using a pill-cutter was the most frequent method recommended by providers to manipulate tablets (87.2%), followed by dissolving tablets in water (25.7%) to create a daily batch (43.7%) and/or dissolving a tablet for each dose (64.6%). Thirty-one percent of providers use pharmacy-compounded hydrocortisone suspension to achieve doses of <2.5 mg. Our survey shows that practices among providers in the dosing of young children with CAH vary greatly and sometimes fall outside of the CAH Guidelines-specifically when attempting to deliver lower, age-appropriate hydrocortisone doses.

This document is currently not available here.

Share

COinS